Good news hasn't budged the price in over a year.
Post# of 148164
Not sure if it's manipulation by MMs or perception of Mgmt's ability/inability to get an approval is just so low nobody's jumping into the pool, or both.
Could also be nerves surrounding 13D's chances of stealing Leronlimab. Some folks just don't want to buy or add out of fear our molecule will be stolen out from under us.
I think Brazil starting gives us a bump but no real move up until interim results and/or EUA, or a partnership announcement.
It sucks but here we are.